June 20, 2024
Policy Article Revisions Summary for June 20, 2024
Joint DME MAC Publication
Outlined below are the principal changes to the DME MAC Policy Article (PA) that has been revised and posted. The policy included is Nebulizers. Please review the entire Local Coverage Determination (LCD) and related PA for complete information.
Nebulizers
PA
Revision Effective Date: 01/01/2024
NON-MEDICAL NECESSITY COVERAGE AND PAYMENT RULES:
- Revised: Information pertaining to aztreonam lysine and amikacin liposome, to clarify that the inhalation solutions, nebulizer, and related accessories are noncovered under the Medicare Part B DME benefit
- Added: "(The aztreonam lysine inhalation solution and related accessories may be eligible for coverage under a different Medicare benefit (e.g., Medicare Part D))."
- Added: "(The amikacin liposome inhalation solution and related accessories may be eligible for coverage under a different Medicare benefit (e.g., Medicare Part D))."
06/20/2024: At this time the 21st Century Cures Act applies to new and revised LCDs which require comment and notice. This revision is to an article that is not a local coverage determination.
Note: The information contained in this article is only a summary of revisions to the LCDs and/or PAs. For complete information on any topic, you must review the LCDs and/or PAs.